Comparison of citalopram and venlafaxine for depressive disoder
Hua Zhang,Jing Cheng,Wang Gao-hua
2005-01-01
Abstract:Aim: To compare the effect, safety and tolerance of citalopram and venlafaxine for depressive disorder. Methods: The patients, who were tre ated at the out-patient clinic or hospitalization, Center of Mental Health, Renmin Hospital, Wuhan University from October 2003 to October 2004,were divided randomly into 2 groups. Those in the citalopram group with 32 cases were treated with 20-40 mg citalopram per day; Those in the venlafaxine group with 34 cases were treated with 150-225 mg venlafaxine per day for six weeks. Before treatment and at the end of 1st, 2nd, 4th and 6th of treatment, they were assessed by the Hamilton Depression Rating Scale (totally 17 items, the 5 grades score of 0-4 points, 0 point for without this symptom, 4 points for severe), Clinical global impression scale (CGIS) (8 grade score of 0-7 points, 0 point for without disease, 7 points for severe) and Treatment Emergent Symptom Scale (TESS) (5 grade score of 0-4 points, 0 point for without this symptom, 4 points for severe). The effects were assessed by the Hamilton depression rating scale to perform division of reducing score rate, ≥ 25% for effective, ≥ 50% for significant effect, ≥ 75% for recovery. The CGIS was used to divide, ≤ 2 for effective, ≤ 1 for recovery. Results: One in the citalopram group was withdrew at the end of the 4th week; Two in the venlafaxine group, one was at the end of the 2nd week, the other was moved back because of bad reaction. Totally 63 cases were finished the 6-week observation, 31 cases in the citalopram group, 32 cases in the venlafaxine group. (1) Comparison of the scores of Hamilton depression rating scale and CGIS before and after the treatment in the two groups: The comparison of reducing score value of the general score of Hamilton depression rating scale and score of CGIS after treatment in two groups showed that at the end of 2nd and 4th week were bigger in the venlafaxine group than that in the citalopram group (17.47±5.26, 24.33± 6.32; 12.13±5.87, 19.73±6.24; 3.73±1.03, 4.66±0.89; 3.26±1.03, 4.06 ±0.79, P < 0.01, P < 0.05). (2) Comparison of effects in the two groups: The reducing score rate of general score of Hamilton depression rating scale at the end of the 6th week showed that the efficiency, significant effect and recovery rate in the citalopram group and the venlafaxine group was similar (94%, 94%; 68%, 72%; 13%, 25%). The efficiency and recovery rate in the citalopram group by the CGIS were similar (81 %, 84%; 42%, 53%). (3) Comparison of bad reaction incidence: It was lower in the citalopram group than that in the venlafaxine group (13%, 47%, P=0.005). Conclusion: The citalopram and venlafaxine have similar effects on the treatment of depressive disorder, and the response of the venlafaxine occurres earlier than that of the citalopram. They all have good safety, and there are fewer and slighter side effects of citalopram compared with the venlafaxine.